New economic analysis of Voraxaze® (glucarpidase) in
Model simulation shows cost of timely Voraxaze® use is offset by shorter hospital stays and associated with substantially improved clinical outcomes...
Source: globenewswire.com
Stay updated with breaking news from Thomas Kolaras. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Model simulation shows cost of timely Voraxaze® use is offset by shorter hospital stays and associated with substantially improved clinical outcomes...
Philadelphia, April 11, 2022 (GLOBE NEWSWIRE) -- SERB and BTG Specialty Pharmaceuticals are pleased to announce that Thomas Kolaras has been named the...
/PRNewswire/ -- The campaign features real Dupuytren's contracture (DC) patients and aims to address patient complacency, correct myths and misinformation and...